And anti-inflammation Farrell. Oral mucositis and ulcerative proctitis. Proven in human clinical tests. Licensed by Alfasigma. Brilacidin is a unique and valuable molecule. The deal offer needs to be large.
So how can the medical community have completely shut out Brilacidin with its many top level findings of working excellently against most to all bacteria, viruses, and fungi??
One pharma company must realize that there is enough meat on the bone with Brilacidin for both them and IPIX to flourish once the drug gets put to use against the many areas of medicine in which it could help.
Hard for me to believe the medical community is this clueless; must be some other reason and to me it is that they fear what Brilacidin could do to quite a host of Big Pharma popular drugs.
News 
Market Data 
Discover 
